Literature DB >> 32499338

Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy.

Lyrialle W Han1, Lu Wang1, Yuanyuan Shi2, Joseph L Dempsey1, Olesya V Pershutkina1, Moumita Dutta1, Theo K Bammler1, Julia Y Cui1, Qingcheng Mao2.   

Abstract

The microbiome and pregnancy are known to alter drug disposition, yet the interplay of the two physiologic factors on the expression and/or activity of drug metabolizing enzymes and transporters (DMETs) is unknown. This study investigated the effects of microbiome on host hepatic DMETs in mice during pregnancy by comparing four groups of conventional (CV) and germ-free (GF) female mice and pregnancy status, namely, CV nonpregnant, GF non-pregnant, CV pregnant, and GF pregnant mice. Transcriptomic and targeted proteomics of hepatic DMETs were profiled by using multiomics. Plasma bile acid and steroid hormone levels were quantified by liquid chromatography tandem mass spectrometry. CYP3A activities were measured by mouse liver microsome incubations. The trend of pregnancy-induced changes in the expression or activity of hepatic DMETs in CV and GF mice was similar; however, the magnitude of change was noticeably different. For certain DMETs, pregnancy status had paradoxical effects on mRNA and protein expression in both CV and GF mice. For instance, the mRNA levels of Cyp3a11, the murine homolog of human CYP3A4, were decreased by 1.7-fold and 3.3-fold by pregnancy in CV and GF mice, respectively; however, the protein levels of CYP3A11 were increased similarly ∼twofold by pregnancy in both CV and GF mice. Microsome incubations revealed a marked induction of CYP3A activity by pregnancy that was 10-fold greater in CV mice than that in GF mice. This is the first study to show that the microbiome can alter the expression and/or activity of hepatic DMETs in pregnancy. SIGNIFICANCE STATEMENT: We demonstrated for the first time that microbiome and pregnancy can interplay to alter the expression and/or activity of hepatic drug metabolizing enzymes and transporters. Though the trend of pregnancy-induced changes in the expression or activity of hepatic drug metabolizing enzymes and transporters in conventional and germ-free mice was similar, the magnitude of change was noticeably different.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32499338      PMCID: PMC7434050          DOI: 10.1124/dmd.120.000039

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  50 in total

1.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 2.  Pregnancy-related pharmacokinetic changes.

Authors:  Y Tasnif; J Morado; M F Hebert
Journal:  Clin Pharmacol Ther       Date:  2016-05-14       Impact factor: 6.875

3.  Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

Authors:  M F Paine; M Khalighi; J M Fisher; D D Shen; K L Kunze; C L Marsh; J D Perkins; K E Thummel
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

Review 4.  Post-transcriptional gene regulation by mRNA modifications.

Authors:  Boxuan Simen Zhao; Ian A Roundtree; Chuan He
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-03       Impact factor: 94.444

5.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

Review 6.  Species differences in drug transporters and implications for translating preclinical findings to humans.

Authors:  Xiaoyan Chu; Kelly Bleasby; Raymond Evers
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-12-21       Impact factor: 4.481

7.  Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.

Authors:  Diana L Shuster; Linda J Risler; Chao-Kang J Liang; Kenneth M Rice; Danny D Shen; Mary F Hebert; Kenneth E Thummel; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2014-06-04       Impact factor: 4.030

Review 8.  Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.

Authors:  Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-08-10       Impact factor: 3.922

9.  Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.

Authors:  Shingo Takagi; Miki Nakajima; Takuya Mohri; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

Review 10.  Microbial Changes during Pregnancy, Birth, and Infancy.

Authors:  Meital Nuriel-Ohayon; Hadar Neuman; Omry Koren
Journal:  Front Microbiol       Date:  2016-07-14       Impact factor: 5.640

View more
  4 in total

1.  Key hepatic metabolic pathways are altered in germ-free mice during pregnancy.

Authors:  Lyrialle W Han; Yuanyuan Shi; Alison Paquette; Lu Wang; Theo K Bammler; Qingcheng Mao
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

2.  Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice.

Authors:  Masao Togao; Shinnosuke Tajima; Takashi Kurakawa; Gaku Wagai; Jun Otsuka; Shoichi Kado; Koji Kawakami
Journal:  Pharmacol Res Perspect       Date:  2021-12

3.  Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice.

Authors:  Lenka Jourova; Stefan Satka; Veronika Frybortova; Iveta Zapletalova; Pavel Anzenbacher; Eva Anzenbacherova; Petra Petr Hermanova; Barbora Drabonova; Dagmar Srutkova; Hana Kozakova; Tomas Hudcovic
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

4.  Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes.

Authors:  Muluneh M Fashe; John K Fallon; Taryn A Miner; Jacqueline B Tiley; Philip C Smith; Craig R Lee
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.